(Total Views: 459)
Posted On: 03/29/2019 4:32:55 PM
Post# of 36566
King man, that’s been posted quite a few times. The company issued book entry shares for the new immuno spinoff. However it is not a public company yet so no value. They are going to try and merge with another company that has assets, and then public ally list the merged companies. Therefore we don’t know the value yet but the shares are a bookmarker to your account.
(0)
(0)
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.
